Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Hi Phantom, I'm just trying to be clear on this Aspire/dilution matter. I had answered GoIrish1776 that "hopefully they can get needed cash from the Aspire deal without much killing dilution."

Am I correct in my understanding (and please tell me if I am wrong) that the Aspire deal is not the "normal dilution" and won't be as bad as normal as far as dilution for this reason.

In a "normal" deal, it goes like this: a stock price is let's say $10, the company will make a deal to sell shares at $8, so instantly the stock price will drop to around the $8 mark of the deal.
BUT in the Aspire deal, because Marker sets the price, and that price will be set at the current price or an aggregate of the previous 5 days (or something like that), it would be more like, MRKR's price will be let's say $5, they will make a deal to sell additional shares for right at about that same $5 price, so YES, there will be dilution as far as additional shares be added, but am I correct in saying that there will NOT be that dramatic decrease in share price since the deal would be made at or very near whatever the existing stock price is at that time, so we will not be getting killed as we would in a "normal" additional capital deal?

Also, there will be NO warrants with the Aspire deal.

Thank You